PHOSPHORUS-CONTAINING INHIBITORS OF HMG-COA REDUCTASE .3. SYNTHESIS OF HYDROXYPHOSPHINYL-ANALOGS OF THE MEVINIC ACIDS

被引：8

作者：

KARANEWSKY, DS ^{[1
]}

BADIA, MC ^{[1
]}

机构：

[1] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,PRINCETON,NJ 08543

来源：

TETRAHEDRON LETTERS | 1993年 / 34卷 / 01期

关键词：

D O I：

10.1016/S0040-4039(00)60052-7

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

The synthesis of a series of hydroxyphosphinyl-containing analogues of the HMG-CoA reductase inhibitor trans-tetrahydrocompactin is described.

引用

页码：39 / 42

页数：4

共 50 条

[41] HMG-CoA reductase inhibitors increase degradation of collagenase-3 in osteoarthritic chondrocytes.
Toledano, JE
Walling, HW
Irvine, DW
Barmina, OY
Burdge, RE
Jeffrey, JJ
Partridge, NC
FASEB JOURNAL, 2000, 14 (04): : A715 - A715
[42] Synthesis and biological evaluations of condensed pyridine and condensed pyrimidine-based HMG-CoA reductase inhibitors
Suzuki, M
Iwasaki, H
Fujikawa, Y
Sakashita, M
Kitahara, M
Sakoda, R
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (10) : 1285 - 1288
[43] Effect of HMG-CoA reductase inhibitors on proliferation and ecm protein synthesis by rat hepatic stellate cells
Rombouts, K
Wielant, A
Kisanga, E
Hellemans, K
Schuppan, D
Geerts, A
JOURNAL OF HEPATOLOGY, 2001, 34 : 92 - 92
[44] HMG-COA REDUCTASE INHIBITORS .1. SYNTHESIS AND BIOLOGICAL-ACTIVITIES OF ARYL SUBSTITUTED CYCLOALKENES
NEUENSCHWANDER, K
REGAN, J
SCOTESE, A
KOSMIDER, B
BRUNO, J
AMIN, D
GUSTAFSON, S
WEINACHT, J
PERRONE, M
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 125 - MEDI
[45] EFFECTS OF LONG-TERM ADMINISTRATION OF HMG-COA REDUCTASE INHIBITORS ON CHOLESTEROL-SYNTHESIS IN LENS
KALINOWSKI, SS
TANAKA, RD
MOSLEY, ST
EXPERIMENTAL EYE RESEARCH, 1991, 53 (02) : 179 - 186
[46] 3-hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors (statins), atherosclerosis and coronary syndromes
Blum, A
Simsolo, C
Hasin, Y
ATHEROSCLEROSIS, 2004, 175 (01) : 1 - 5
[47] Synthesis of phosphorus-containing amino acid analogs as inhibitors of nitric oxide synthase
Cowart, M
Kowaluk, EA
Kohlhaas, KL
Alexander, KM
Kerwin, JF
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (09) : 999 - 1002
[48] Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis
Kabel, Ahmed M.
Abd Elmaaboud, Maaly A.
Albarraq, Ahmed A.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2015, 96 : 1 - 9
[49] Effects of HMG-CoA Reductase Inhibitors on the Pharmacokinetics of Losartan and Its Main Metabolite EXP-3174 in Rats: Possible Role of CYP3A4 and P-gp Inhibition by HMG-CoA Reductase Inhibitors
Yang, Si-Hyung
Choi, Jun-Shik
Choi, Dong-Hyun
PHARMACOLOGY, 2011, 88 (1-2) : 1 - 9
[50] CATARACTS BY LIPID LOWERING DRUGS - 3 DIFFERENT HMG-COA REDUCTASE INHIBITORS STUDIED IN HYPERCHOLESTEROLEMIC RABBITS
BEHRENSBAUMANN, W
THIERY, J
RESEARCH IN EXPERIMENTAL MEDICINE, 1992, 192 (01) : 7 - 11

← 1 2 3 4 5 →